Results 211 to 220 of about 11,992,356 (248)

Physical activity perceptions, barriers, and needs among nursing home residents: an explanatory sequential mixed-methods study. [PDF]

Front Public Health
Kim JA, Kim H, Jang HY.
europepmc   +1 more source

Epigenetic silencing of the liver‐specific lncRNA LUNAR promotes liver cancer progression via NOTCH activation

Molecular Oncology, EarlyView.
LUNAR is a liver‐specific long noncoding RNA (lncRNA) that is highly expressed in normal liver but becomes epigenetically silenced in hepatocellular carcinoma through promoter hypermethylation. Loss of LUNAR is associated with NOTCH activation, epithelial–mesenchymal transition, and metastasis, whereas restoring LUNAR restrains metastatic progression ...
Se Ha Jang, Hyung Seok Kim, Geum Ok Baek, Moon Gyeong Yoon, Su In Lee, Jee‐Yeong Jeong, Ji Eun Han, Soon Sun Kim, Jae Youn Cheong, Jung Woo Eun   +9 more
wiley   +1 more source

Does the breathing response limit exercise tolerance in patients weaning from mechanical ventilation? [PDF]

ERJ Open Res
Nijhoff T, Zoethout S, Klooster E, Oosterwegel A, Millen X, Kök M, van der Sleen BJ, Greven T, Langeveld B, van den Oever HLA.   +9 more
europepmc   +1 more source

CEACAM1 participation in breast cancer progression

Molecular Oncology, EarlyView.
In invasive breast cancer (BC), CEACAM1 shifts from an apical to a uniform membranous/cytoplasmic pattern, or is lost, as tumors dedifferentiate, inversely tracking the Ki‐67 proliferative index. In MCF‐7 cells, only CEACAM1‐4L suppresses proliferation, repressing cell cycle and growth factor genes.
Mykola Lyndin, Irina Kube‐Golovin, Anatolii Romaniuk, Gunther Wennemuth   +3 more
wiley   +1 more source

Lexical Context Effects During Reading: The Impact of Vocabulary Knowledge and Word Frequency. [PDF]

J Eye Mov Res
Abraham AN, Folk JR.
europepmc   +1 more source

Pharmacological chromatin remodeling enhances response to estrogen therapy in ER+ breast cancer

Molecular Oncology, EarlyView.
Estrogen therapy elicits clinical benefit in ~ 30% of patients with endocrine‐resistant estrogen receptor (ER)‐positive breast cancer. Based on findings that ER transcriptional activation underlies response to estrogen therapy, we tested the effects of epigenetic dysregulation via pharmacological inhibition of histone deacetylases (HDACi).
Anneka L. Johnson Thomas, Barbara Karakyriakou, Patricia C. Muskus, Alyssa M. Roberts, Justin Rendleman, Alexa Warren, Hanxu Lu, Kimberly A. Birmingham, Malone K. Friedman, Abigail E. Goen, Huijuan Yang, Owen M. Wilkins, Fred W. Kolling, Eugene Demidenko, Julie M. Jorns, Brock C. Christensen, Todd W. Miller   +16 more
wiley   +1 more source

Power distribution system blackstart restoration using renewable energy. [PDF]

Nat Commun
Shi W, Bai C, Wang Z.
europepmc   +1 more source

Chip-scale modulation-free laser stabilization using vacuum-gap micro-Fabry-Pérot cavity. [PDF]

Sci Adv
Idjadi MH, Cheng H, Ashtiani F, Li B, Kim K, Jin N, Quinlan F, Rakich PT.   +7 more
europepmc   +1 more source

Implementation of the In Vitro Seizure Liability Assay (iLA^seizure) in Drug Discovery and Development: Mechanism of Action Case Studies. [PDF]

Pharmacol Res Perspect
Rockley K, Roberts R, Jennings H, Jones K, Maizières MA, Morton M.   +5 more
europepmc   +1 more source